7D Surgical Expanding Footprint in the European Market: Surpasses its 50th Unit Sale

7D Surgical, based in Toronto, Canada, is expanding its footprint into the European Market with multiple units already placed. 7D Surgical has also completed several spinal surgical cases and tissue labs utilizing the FLASH™ Navigation System in Germany and Switzerland.

7D Surgical notes since sales first commenced in 2018, 7D Surgical has surpassed 50 units sold in just over two years.

7D Surgical Beau Standish, Chief Executive Officer said, “Aggressively expanding our international footprint has been a strategic priority for the company in 2020.” He added, “We have now successfully launched in the United States, Canada, Singapore, Australia, New Zealand, and the Caribbean and are excited to enter into the European market to share our machine-vision technology with the global healthcare community.”

7D Surgical has developed technology, similar to GPS navigation in self-driving vehicles, to create a three-dimensional image for surgical navigation in just seconds, resulting in shorter and more efficient spinal and cranial procedures. The FLASH™ Navigation System uses only visible light, eliminating the patient and staff exposure to intraoperative radiation. It is the only approved image guidance system that utilizes this novel and proprietary camera-based technology, coupled with machine-vision algorithms to eliminate the long-standing frustrations with legacy surgical navigation platforms. The speed, accuracy, and efficiency combined with a fundamentally streamlined surgical workflow provides significant economic value and harnesses the true potential of image guidance – all while enabling a safe and radiation-free surgical environment.

In addition to its rapid global expansion, 7D Surgical has achieved numerous milestones in recent months, including surpassing its 13,000th pedicle screw guided with the FLASH™ Navigation System. The company also completed its first pediatric installation in the United States, adding to their global footprint of pediatric hospitals. The FLASH™ Navigation System is ideally suited to deliver navigation technology that is safe and radiation-free for this patient population.

“I have been following navigation for many years, but never felt right about the technology out there because it was bulky, cumbersome, and slow. The 7D System completely changed that and has great, cutting-edge technology that is simple and efficient,” said Dr. Chris Comstock, pediatric spine surgeon at Driscoll Children’s Hospital in Corpus Christi, Texas. “I’ve used it on very complex deformity cases, and it worked beautifully. It is very compact, easy to mobilize, surgeon friendly to operate, and extremely fast and accurate… and the fact that it eliminates the radiation exposure to myself and my patients is a game-changer.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."
Adrian Mendes, Perimeter's Chief Executive Officer, stated, "We believe this additional commercial placement within a major national healthcare system – representing the fifth unit placed with this existing customer network – demonstrates that surgeon end users, as well as other stakeholders within the broader healthcare system, see the value of our technology and are recommending it to their peers. Our aim is to make Perimeter's innovative technology the standard of care in cancer surgery."

By using this website you agree to accept Medical Device News Magazine Privacy Policy